ifosfamide has been researched along with Nephritis, Interstitial in 6 studies
Nephritis, Interstitial: Inflammation of the interstitial tissue of the kidney. This term is generally used for primary inflammation of KIDNEY TUBULES and/or surrounding interstitium. For primary inflammation of glomerular interstitium, see GLOMERULONEPHRITIS. Infiltration of the inflammatory cells into the interstitial compartment results in EDEMA, increased spaces between the tubules, and tubular renal dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report three cases of women with breast cancer who developed renal impairment following treatment with high-dose ifosfamide." | 7.70 | Tubulointerstitial nephritis following high-dose ifosfamide in three breast cancer patients. ( Hill, PA; Power, DA; Prince, HM, 2000) |
| "We report three cases of women with breast cancer who developed renal impairment following treatment with high-dose ifosfamide." | 3.70 | Tubulointerstitial nephritis following high-dose ifosfamide in three breast cancer patients. ( Hill, PA; Power, DA; Prince, HM, 2000) |
| "In addition, polyploidy of TEC was observed to correlate with loss of lysozyme staining." | 1.91 | Cellular senescence in kidney biopsies is associated with tubular dysfunction and predicts CKD progression in childhood cancer patients with karyomegalic interstitial nephropathy. ( Broekhuizen, R; Goldschmeding, R; Haveman, LM; Janssens, GO; Keijzer-Veen, MG; Knoppert, SN; Lilien, MR; Nguyen, TQ; Stokman, MF; Valentijn, FA; van den Berg, G; van den Heuvel-Eibrink, MM; van Kempen, S, 2023) |
| "Ifosfamide is a nitrogen mustard alkylating agent used as both a first-line and a salvage chemotherapeutic agent in the treatment of testicular germ cell tumors, various sarcomas, carcinomas, and some lymphomas." | 1.40 | Chronic Ifosfamide toxicity: kidney pathology and pathophysiology. ( Akilesh, S; Duffield, JS; Juaire, N; Smith, KD, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Knoppert, SN | 1 |
| Keijzer-Veen, MG | 1 |
| Valentijn, FA | 1 |
| van den Heuvel-Eibrink, MM | 1 |
| Lilien, MR | 1 |
| van den Berg, G | 1 |
| Haveman, LM | 1 |
| Stokman, MF | 1 |
| Janssens, GO | 1 |
| van Kempen, S | 1 |
| Broekhuizen, R | 1 |
| Goldschmeding, R | 1 |
| Nguyen, TQ | 1 |
| Akilesh, S | 1 |
| Juaire, N | 1 |
| Duffield, JS | 1 |
| Smith, KD | 1 |
| McCulloch, T | 1 |
| Prayle, A | 1 |
| Lunn, A | 1 |
| Watson, AR | 1 |
| Friedlaender, MM | 1 |
| Haviv, YS | 1 |
| Rosenmann, E | 1 |
| Peylan-Ramu, N | 1 |
| Hill, PA | 1 |
| Prince, HM | 1 |
| Power, DA | 1 |
6 other studies available for ifosfamide and Nephritis, Interstitial
| Article | Year |
|---|---|
Cellular senescence in kidney biopsies is associated with tubular dysfunction and predicts CKD progression in childhood cancer patients with karyomegalic interstitial nephropathy.
Topics: Biopsy; Cellular Senescence; Child; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Kidney; | 2023 |
Chronic Ifosfamide toxicity: kidney pathology and pathophysiology.
Topics: Antineoplastic Agents, Alkylating; Biopsy; Dose-Response Relationship, Drug; Drug Administration Sch | 2014 |
Karyomegalic-like nephropathy, Ewing's sarcoma and ifosfamide therapy.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Biopsy; Cell Nucleus Shape; Chronic Disease; Disease | 2011 |
End-stage renal interstitial fibrosis in an adult ten years after ifosfamide therapy.
Topics: Adult; Antineoplastic Agents, Alkylating; Fibrosis; Humans; Ifosfamide; Kidney; Kidney Failure, Chro | 1998 |
Tubulointerstitial nephritis following high-dose ifosfamide in three breast cancer patients.
Topics: Adult; Antineoplastic Agents, Alkylating; Breast Neoplasms; Carcinoma, Ductal, Breast; Contraindicat | 2000 |
Ifosfamide for children with solid tumours.
Topics: Child; Child, Preschool; Glomerular Filtration Rate; Humans; Ifosfamide; Neoplasms; Nephritis, Inter | 1990 |